Researchers have identified a key molecular interaction that accelerates Parkinson’s disease by damaging the brain’s energy systems. They designed a new treatment that intercepts this harmful process, ...
Researchers capture first-of-its-kind video of dynein–Lis1 protein interaction, supporting future drug development for neurological disorders. Our cells rely on microscopic highways and specialized ...
Researchers have created a platform, called SIMPL2, that revolutionizes the study of protein-protein interactions by simplifying detection while improving measurement accuracy. While protein-protein ...